11:09 AM EDT, 05/04/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week lower late Monday morning, falling 0.70% to 1,803.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company argenx (ARGX), which climbed 8.1% and 1.9% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and biopharmaceutical company Grifols ( GRFS ) , which advanced 1.8% and 1.5% respectively.

The decliners from continental Europe were led by pharmaceutical company Sanofi ( SNY ) and lender Banco Bilbao Vizcaya Argentaria ( BBVA ) , which dropped 5.5% and 4.2% respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical company Cellectis ( CLLS ) , which lost 3.3% and 1% respectively.

The gainers from the UK were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 9.2% and 2.8% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Amarin ( AMRN ) , which were up 2.3% and 2.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and cruise line operator Carnival (CUK), which fell 2.2% and 1.6% respectively. They were followed by pharmaceutical company GSK (GSK) and biotech firm Trinity Biotech ( TRIB ) , which were down 1.2% and 0.4% respectively.